Evidence map›Paper›PMID 29925258›Full record

ReviewAnnual review of biochemistry2018

The Molecular Basis of G Protein-Coupled Receptor Activation.

William I Weis, Brian K Kobilka

Open access · bronzeAbstract readReview
In one paragraph

Review in Annual review of biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 688 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
688citing papers in PubMed, 1 pooled it
36.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

688 citing papers in PubMed, 1 synthesis or guideline pooled it, 1,207 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Mechanisms of XCR1 Membrane Trafficking and Constitutive Endocytosis.Basic & clinical pharmacology & toxicology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A Chemigenetic Fluorescence Lifetime Biosensor for Dopamine Sensing.bioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Structural basis of opioid receptor activation by PCP and ketamine.Nature structural & molecular biology · 2026
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. The Origins of GPCRs.International journal of molecular sciences · 2026
    Review

628 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

William I WeisDepartment of Structural Biology, Stanford University School of Medicine, Stanford, California 94305, USA; email: bill.weis@stanford.edu.
Brian K KobilkaDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California 94305, USA; email: kobilka@stanford.edu.
Stanford University · US

Funding

Structure and dynamics of G protein coupled receptor-G protein complexesR01GM083118 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KOBILKA, BRIAN K, SKINIOTIS, GEORGIOS · 2008 to 2023
$8.3M
THE MECHANISM OF BETA2 ADRENOCEPTOR ACTIVATIONR01NS028471 · NINDS · STANFORD UNIVERSITY · PI KOBILKA, BRIAN K · 1990 to 2021
$6.7M
NIGMS NIH HHS R01 GM083118NINDS NIH HHS R01 NS028471
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) mediate the majority of cellular responses to external stimuli. Upon activation by a ligand, the receptor binds to a partner heterotrimeric G protein and promotes exchange of GTP for GDP, leading to dissociation of the G protein into α and βγ subunits that mediate downstream signals. GPCRs can also activate distinct signaling pathways through arrestins. Active states of GPCRs form by small rearrangements of the ligand-binding, or orthosteric, site that are amplified into larger conformational changes. Molecular understanding of the allosteric coupling between ligand binding and G protein or arrestin interaction is emerging from structures of several GPCRs crystallized in inactive and active states, spectroscopic data, and computer simulations. The coupling is loose, rather than concerted, and agonist binding does not fully stabilize the receptor in an active conformation. Distinct intermediates whose populations are shifted by ligands of different efficacies underlie the complex pharmacology of GPCRs.

Indexed as

Allosteric RegulationBinding SitesConserved SequenceCrystallography, X-RayEnergy MetabolismHumansLigandsModels, MolecularProtein ConformationReceptors, G-Protein-CoupledLigandsReceptors, G-Protein-Coupled7-TM receptorsallosteryenergy landscapeGPCRG protein–coupled receptorβ2-adrenergic receptor

Identifiers

PMID29925258
PMCPMC6535337
OpenAlexW2809303314

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.